Page 3 - Trend Trader News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Wall Street Daily Dear The Cryptosphere can’t contain its enthusiasm over the breaking news: Visa Inc. (V) will soon accept settlement in USD coin, a cryptocurrency pegged to the U.S. dollar. As one of the largest payment processors in the world, you couldn’t ask for a bigger validation of digital currencies. Even as a crypto skeptic, I’ll concede the news represents a significant step towards potential mainstream adoption of digital currencies. But it’s Digital Fast-Forward As I’ve told you before, the pandemic is proving to be the biggest catalyst for the adoption of contact...

Keep Buying the Dips in These 3 Sectors Dear But please don’t join in on the near-sighted panic! As I told you earlier last week, the sudden increase in 10-year Treasury yields is blinding many investors to the sobering fact that we’re simply returning to pre-pandemic levels that are normal, not dangerous. They’ll figure it out eventually. But while they do, I highly recommend you treat the resulting volatility as an opportunity to “buy the dip” in these three top sectors… Semis or Die Interestingly enough, the pandemic didn’t put a dent in innovation. Global patent filings act...

If you think the GameStop Corp. (GME) saga only involves a small handful of heavily-shorted stocks, think again… Pretty much every heavily-shorted stock in the Russell 3000 with a nose-bleed valuation is surging. But that does NOT mean a GME endorsement. So, where SHOULD you be investing? Glad you asked…

Don’t Buy Any Covid-19 Vaccine Stocks Until You Read This Dear Wall Street Daily Reader, With shares of Novavax, Inc. (NVAX) doubling during the last few weeks of January — and surging more than 3,000% over the last year — investors are on the lookout for the next Covid-19 vaccine stock set to soar. I don’t blame them. But it’s no easy task. Case in point: according to the latest data from www.ClinicalTrials.gov, there are currently 4,636 Covid-19 treatments and trials underway. That’s up by 376 trials since I last checked… which was the day before! Sorting through all those t...

Trend Trader Daily editor and founder, Lou Basenese, is back with his prediction on 2021’s top performer: biotech. “It’s now become vital to survival. Literally. And that’s not going to change anytime soon.” Read on to find out why, and how you can get in on the Biotech Boom 2.0.